This invite-only luncheon brings together a curated group of investors to explore the evolving financial landscape shaping biotech and synthetic biology. Hosted at SynBioBeta 2025, the event offers a unique opportunity to connect with capital allocators and venture capitalists navigating today’s high-stakes funding environment. In addition to high-level networking, the luncheon will feature a panel conversation titled Strategic Perspectives on the Evolving Capital Landscape. Moderated by TD Securities, the session will examine how investment strategies are adapting in response to tighter funding conditions, rising interest rates, and shifting exit dynamics. Joining the conversation are Jenny Rooke (Genoa Ventures), Joško Bobanović (Sofinnova Partners), and Karl Handelsman (Codon Capital)—three seasoned investors with deep insight into the capital flows shaping the future of biotech. Together, they will share what they're seeing on the ground, how they’re thinking about risk and opportunity, and what founders need to know to raise in this environment. https://lu.ma/bol859y4

In this session, we'll discuss the pivotal role of infrastructure investments in accelerating the bioeconomy. Harnessing the full potential of synthetic biology requires access to expensive infrastructure for biomanufacturing and scale-up. We'll dive into how investors, CMOs, and startups are capitalizing on this opportunity space to accelerate bringing products to market.